873 related articles for article (PubMed ID: 17562543)
1. The receptor attributable to C-type natriuretic peptide-induced differentiation of osteoblasts is switched from type B- to type C-natriuretic peptide receptor with aging.
Kaneki H; Kurokawa M; Ide H
J Cell Biochem; 2008 Feb; 103(3):753-64. PubMed ID: 17562543
[TBL] [Abstract][Full Text] [Related]
2. C-type natriuretic peptide enhances amylase release through NPR-C receptors in the exocrine pancreas.
Sabbatini ME; Rodríguez M; di Carlo MB; Davio CA; Vatta MS; Bianciotti LG
Am J Physiol Gastrointest Liver Physiol; 2007 Nov; 293(5):G987-94. PubMed ID: 17702953
[TBL] [Abstract][Full Text] [Related]
3. Reduced affinity of iodinated forms of Tyr0 C-type natriuretic peptide for rat natriuretic peptide receptor B.
Thibault G; Grove KL; Deschepper CF
Mol Pharmacol; 1995 Dec; 48(6):1046-53. PubMed ID: 8848004
[TBL] [Abstract][Full Text] [Related]
4. Stimulation by C-type natriuretic peptide of the differentiation of clonal osteoblastic MC3T3-E1 cells.
Inoue A; Hiruma Y; Hirose S; Yamaguchi A; Furuya M; Tanaka S; Hagiwara H
Biochem Biophys Res Commun; 1996 Apr; 221(3):703-7. PubMed ID: 8630025
[TBL] [Abstract][Full Text] [Related]
5. eNOS, nNOS, cGMP and protein kinase G mediate the inhibitory effect of pancreastatin, a chromogranin A-derived peptide, on growth and proliferation of hepatoma cells.
Díaz-Troya S; Najib S; Sánchez-Margalet V
Regul Pept; 2005 Feb; 125(1-3):41-6. PubMed ID: 15582712
[TBL] [Abstract][Full Text] [Related]
6. Hyperammonemia inhibits the natriuretic peptide receptor 2 (NPR-2)-mediated cyclic GMP synthesis in the astrocytic compartment of rat cerebral cortex slices.
Zielińska M; Fresko I; Konopacka A; Felipo V; Albrecht J
Neurotoxicology; 2007 Nov; 28(6):1260-3. PubMed ID: 17629948
[TBL] [Abstract][Full Text] [Related]
7. Natriuretic peptide receptor-C signaling and regulation.
Anand-Srivastava MB
Peptides; 2005 Jun; 26(6):1044-59. PubMed ID: 15911072
[TBL] [Abstract][Full Text] [Related]
8. Presence and biological activity of C-type natriuretic peptide-dependent guanylate cyclase-coupled receptor in the penile corpus cavernosum.
Kim SZ; Kim SH; Park JK; Koh GY; Cho KW
J Urol; 1998 May; 159(5):1741-6. PubMed ID: 9554404
[TBL] [Abstract][Full Text] [Related]
9. C-type natriuretic peptide as an autocrine/paracrine regulator of osteoblast. Evidence for possible presence of bone natriuretic peptide system.
Suda M; Tanaka K; Fukushima M; Natsui K; Yasoda A; Komatsu Y; Ogawa Y; Itoh H; Nakao K
Biochem Biophys Res Commun; 1996 Jun; 223(1):1-6. PubMed ID: 8660352
[TBL] [Abstract][Full Text] [Related]
10. Presence of functional type B natriuretic peptide receptor in human ocular cells.
Pang IH; Shade DL; Matsumoto S; Steely HT; DeSantis L
Invest Ophthalmol Vis Sci; 1996 Aug; 37(9):1724-31. PubMed ID: 8759339
[TBL] [Abstract][Full Text] [Related]
11. cAMP inhibits natriuretic peptide receptor-B activity and increases C-type natriuretic peptide in FRTL-5 rat thyroid cells.
Sellitti DF; Puggina E; Lagranha C; Doi SQ
J Endocrinol; 2004 Jan; 180(1):23-34. PubMed ID: 14709141
[TBL] [Abstract][Full Text] [Related]
12. Signaling and distribution of NPR-Bi, the human splice form of the natriuretic peptide receptor type B.
Hirsch JR; Skutta N; Schlatter E
Am J Physiol Renal Physiol; 2003 Aug; 285(2):F370-4. PubMed ID: 12709393
[TBL] [Abstract][Full Text] [Related]
13. Atrial natriuretic factor and C-type natriuretic peptide induce retraction of human thyrocytes in monolayer culture via guanylyl cyclase receptors.
Sellitti DF; Lagranha C; Perrella G; Curcio F; Doi SQ
J Endocrinol; 2002 Apr; 173(1):169-76. PubMed ID: 11927396
[TBL] [Abstract][Full Text] [Related]
14. Negative inotropic effects of C-type natriuretic peptide are attenuated in hypertrophied ventricular myocytes associated with reduced cyclic GMP production.
Moalem J; Davidov T; Zhang Q; Grover GJ; Weiss HR; Scholz PM
J Surg Res; 2006 Sep; 135(1):38-44. PubMed ID: 16600302
[TBL] [Abstract][Full Text] [Related]
15. Stimulatory and Inhibitory regulation of lipolysis by the NPR-A/cGMP/PKG and NPR-C/G(i) pathways in rat cultured adipocytes.
Nishikimi T; Iemura-Inaba C; Akimoto K; Ishikawa K; Koshikawa S; Matsuoka H
Regul Pept; 2009 Feb; 153(1-3):56-63. PubMed ID: 19027799
[TBL] [Abstract][Full Text] [Related]
16. Signaling pathways involved in atrial natriuretic factor and dopamine regulation of renal Na+, K+ -ATPase activity.
Correa AH; Choi MR; Gironacci M; Valera MS; Fernández BE
Regul Pept; 2007 Jan; 138(1):26-31. PubMed ID: 17005263
[TBL] [Abstract][Full Text] [Related]
17. Atrial natriuretic peptide-C receptor-induced attenuation of adenylyl cyclase signaling activates phosphatidylinositol turnover in A10 vascular smooth muscle cells.
Mouawad R; Li Y; Anand-Srivastava MB
Mol Pharmacol; 2004 Apr; 65(4):917-24. PubMed ID: 15044621
[TBL] [Abstract][Full Text] [Related]
18. Effect of cyclic GMP-increasing agents nitric oxide and C-type natriuretic peptide on bovine chromaffin cell function: inhibitory role mediated by cyclic GMP-dependent protein kinase.
Rodriguez-Pascual F; Miras-Portugal MT; Torres M
Mol Pharmacol; 1996 Jun; 49(6):1058-70. PubMed ID: 8649344
[TBL] [Abstract][Full Text] [Related]
19. C-type natriuretic peptide is a Schwann cell-derived factor for development and function of sensory neurones.
Kishimoto I; Tokudome T; Horio T; Soeki T; Chusho H; Nakao K; Kangawa K
J Neuroendocrinol; 2008 Nov; 20(11):1213-23. PubMed ID: 18752656
[TBL] [Abstract][Full Text] [Related]
20. C-type natriuretic peptide/guanylate cyclase B system in ATDC5 cells, a chondrogenic cell line.
Suda M; Tanaka K; Yasoda A; Komatsu Y; Chusho H; Miura M; Tamura N; Ogawa Y; Nakao K
J Bone Miner Metab; 2002; 20(3):136-41. PubMed ID: 11984695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
